BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8819891)

  • 1. Oxalate-induced damage to renal tubular cells.
    Scheid CR; Koul HK; Kennington L; Hill WA; Luber-Narod J; Jonassen J; Honeyman T; Menon M
    Scanning Microsc; 1995; 9(4):1097-105; discussion 1105-7. PubMed ID: 8819891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxalate: from crystal formation to crystal retention.
    Koul HK; Koul S; Fu S; Santosham V; Seikhon A; Menon M
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S417-21. PubMed ID: 10541276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of oxalate-induced nephrotoxicity by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental rat model.
    Lenin M; Thiagarajan A; Nagaraj M; Varalakshmi P
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):265-70. PubMed ID: 11993719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in MDCK and LLC-PK1 cells exposed to oxalate and calcium oxalate monohydrate crystals.
    Hackett RL; Shevock PN; Khan SR
    Scanning Microsc; 1995 Jun; 9(2):587-96. PubMed ID: 8714751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
    Khan SR
    Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells.
    Scheid C; Koul H; Hill WA; Luber-Narod J; Jonassen J; Honeyman T; Kennington L; Kohli R; Hodapp J; Ayvazian P; Menon M
    J Urol; 1996 Mar; 155(3):1112-6. PubMed ID: 8583575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion and endocytosis of calcium oxalate crystals on renal tubular cells.
    Kohjimoto Y; Ebisuno S; Tamura M; Ohkawa T
    Scanning Microsc; 1996; 10(2):459-68; discussion 468-70. PubMed ID: 9813624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury.
    Tsujihata M
    Int J Urol; 2008 Feb; 15(2):115-20. PubMed ID: 18269444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalate-induced changes in the viability and growth of human renal epithelial cells.
    Jonassen JA; Cooney R; Kennington L; Gravel K; Honeyman T; Scheid CR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S446-51. PubMed ID: 10541281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic role of phycocyanin: a study of oxalate mediated renal cell injury.
    Farooq SM; Asokan D; Kalaiselvi P; Sakthivel R; Varalakshmi P
    Chem Biol Interact; 2004 Aug; 149(1):1-7. PubMed ID: 15294440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants.
    Thamilselvan S; Khan SR; Menon M
    Urol Res; 2003 Mar; 31(1):3-9. PubMed ID: 12624656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of SEM in the study of oxalate induced experimental nephrolithiasis.
    Khan SR; Hackett RL
    Scan Electron Microsc; 1980; (3):379-86. PubMed ID: 7414280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal tubular alteration by crystalluria in stone disease-an experimental study by means of MDCK cells.
    Lahme S; Feil G; Strohmaier WL; Bichler KH; Stenzl A
    Urol Int; 2004; 72(3):244-51. PubMed ID: 15084771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Future perspective on the prevention of nephrolithiasis].
    Kohjimoto Y; Shinka T; Morimoto S; Nishihata M
    Hinyokika Kiyo; 2004 Aug; 50(8):591-6. PubMed ID: 15471083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of uropontin in calcium oxalate lithogenesis].
    Paulhac P; Desgrandchamps F; Dumas JP; Teillac P; Le Duc A; Colombeau P
    Prog Urol; 2002 Feb; 12(1):114-7. PubMed ID: 11980003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxalate-induced exposure of phosphatidylserine on the surface of renal epithelial cells in culture.
    Wiessner JH; Hasegawa AT; Hung LY; Mandel NS
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S441-5. PubMed ID: 10541280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.